Helping to share the web since 1996
Tofacitinib (CP-690550,Tasocitinib) is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States.
There are no posts for this page yet.
Upgrade Options